Placeholder

$4,175.00$7,375.00

Clear
SKU: N/A Category:

In Vitro Diagnostics/IVD Market by Product (Reagent, Instruments, Software, Service), Technique [Immunoassay, Clinical Chemistry (Lipids, Renal, Thyroid), PCR], Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC) – Global Forecast To 2024

Upto 20% Q4 Discount Until Jan 5th 2019.

  • Dec, 2018
  • pages: 301
  • formats:* PDF
  • Report ID: MRMD-10449

Product Description

The global IVD market is expected to grow at a CAGR of 5.7% from 2018 to reach $87.21 billion by 2024. IVDs allow healthcare providers to efficiently and accurately diagnose, monitor, screen, and assess predispositions to diseases. Owing to rising geriatric population & subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments by diagnostic laboratories, and growing adoption of personalized medicine & point-of-care testing- this industry has witnessed a steady growth. Further, development of condition-specific markers and tests and growing demand for IVD products in emerging countries provides significant opportunities for the various stakeholders in this market.

Rising adoption of fully automated instruments is propelling the growth of the global IVD market

With increasing competition and demand for higher levels of performance, automation has become essential. Driven by increasing test volumes, the requirements for processing higher-complexity assays, and the need to reduce turnaround time- clinical laboratories are increasingly adopting automation solutions. The IVD market is swinging steadily towards semi-automated and fully-automated laboratory instruments. Some advantages of automation include decrease in the turnaround time (TAT) for the investigations, high accuracy & reproducibility, speedy delivery of reports to the clinician and patients, and less requirement of manpower due to less human intervention and fewer laboratory errors during pre-analytical, analytical, and post-analytical processes which makes it cost-effective. Shrinking field of qualified laboratory personnel is further fueling the need for laboratory automation.

Growing adoption of personalized medicine supports the market growth

According to Personalized Medicine Coalition (PMC) (a nonprofit umbrella organization of healthcare and IT companies, providers, payers, patient advocacy groups, academic, and government organizations), globally, number of personalized medicines that are commercially available have increased steadily from 5 in 2008 to 132 in 2016. This increase was mainly attributed to growth in the investment from biopharmaceutical manufacturers, scientific developments in genomic sequencing, and growing influx of funding from governments. Further various governments across the globe are providing grants for the development of precision medicine which is further driving the growth of the IVD market.

Key findings in the global IVD market study:

Reagents and kits generated large proportion of revenue

Factors such as incessant product launches, number of on-going research activities, and growing prevalence of various acute as well as chronic infectious diseases are driving the adoption of reagents & kits.

Immunoassay to witness the largest demand through 2024

Immunoassay commanded the largest share of the global IVD market owing to their greater adoption attributed to advantages such as inherent specificity, high throughput, high sensitivity, and low cost. On the other hand, molecular diagnostics is slated to grow faster due to growing interest in personalized medicine.

Infectious diseases segment continue to dominate the IVD market

Infectious diseases commanded the largest share of the global IVD market. This is mainly due to large volume of IVD tests performed for infectious diseases, high incidence of various infectious diseases, and continuous technological advancements in the tests used for the detection of such diseases. According to WHO, infectious diseases such as TB is one of the leading causes of deaths worldwide. In 2016, 10.4 million people suffered from TB, and 1.7 million died with over 95% of TB deaths in low- and middle-income countries (LMICs). Also, it is the leading cause of death for HIV-positive people with 40% of HIV deaths were attributed to TB in 2016. Therefore, high incidence and mortality associated with infectious diseases is driving the demand for IVD tests.

Hospital laboratories to dominate the global IVD market

Hospital laboratories commanded the largest share of the global IVD market with the rising prevalence of infectious and non-communicable diseases in developing and developed countries, high incidence of hospital-acquired infections (HAIs), and rising aging population. According to the WHO, in recent years, RDT testing has been significantly expanded across the globe. According to the American Journal of Tropical Medicine and Hygiene, every year, more than a thousand patients are hospitalized in the U.S. for malaria infections. Moreover, the number of imported malaria cases has steadily increased in the U.S. Owing to this, hospital laboratories are performing large number of rapid diagnostics tests.

Asia-Pacific: Fastest growing regional market

North America commanded the largest share of the global IVD market in 2017, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific will be the fastest growing regional market due to improving healthcare infrastructure; growing access to healthcare services; increasing incidence of infectious and non-communicable diseases with aging population; and growing income levels in the region.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2015-2018). The key players profiled in the global IVD market research report are Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens Healthcare, Thermo Fisher Scientific Inc., Sysmex Corporation, bioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Qiagen N.V., and Agilent Technologies, Inc. 

Scope of the Report:

Market by Product

  • Reagents & Kits
  • Instruments
  • Software & Services

 

Market by Technique

  • Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassays
      • Fluorescence Immunoassays
      • Colorimetric Immunoassays
    • Radioimmunoassay
    • Rapid Tests
    • Western Blotting
    • Enzyme-Linked Immunospot Assays
  • Clinical Chemistry
    • Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
  • Molecular Diagnostics
    • Polymerase Chain Reaction
    • Isothermal Nucleic Acid Amplification Technology
    • Microarray
    • Hybridization
    • DNA Sequencing & Next-Generation Sequencing
  • Microbiology
  • Hematology
  • Coagulation and Hemostasis
  • Urinalysis
  • Other IVD Technologies

Market by Application

  • Infectious Diseases
  • Diabetes
  • Cancer/Oncology
  • Endocrinology
  • Cardiology
  • Nephrology
  • Others

Market by End User

  • Hospitals Laboratories
  • Independent Reference Laboratories
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Academic and Research Institutes

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

 

TABLE OF CONTENTS

1. Introduction

1.1. Market Ecosystem
1.2. Currency and Limitations

1.2.1. Currency
1.2.2. Limitations

1.3. Key Stakeholders

2. Research Methodology

2.1. Research Process

2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
4. Market Insights

4.1. Introduction
4.2. Drivers

4.2.1. Rising Geriatric Population Coupled with the Growing Prevalence of Chronic and Infectious Diseases
4.2.2. Rising Adoption of Fully Automated Instruments and Automation in Laboratories
4.2.3. Growing Adoption of Personalized Medicine
4.2.4. Increasing Adoption of Point-Of-Care (PoC) Testing

4.3. Restraints

4.3.1. Unfavorable Reimbursement Scenario

4.4. Opportunities

4.4.1. Development of Condition-Specific Markers and Tests
4.4.2. Growth Opportunities in Emerging Countries

4.5. Challenges

4.5.1. Changing Regulatory Landscape
4.5.2. Product-Design and Cost Related Challenges In The Uptake Of New Technologies In Developing Countries
4.5.3. Dearth of Qualified Laboratory Technologists

4.6. Market Share Analysis

5. Global In Vitro Diagnostics Market, By Product

5.1. Introduction
5.2. Reagents & Kits
5.3. Instruments
5.4. Software and Services

6. In Vitro Diagnostics Market, By Techniques

6.1. Introduction
6.2. Immunoassay

6.2.1. Enzyme-Linked Immunosorbent Assay

6.2.1.1. Colorimetric Immunoassays
6.2.1.2. Chemiluminescence Immunoassays
6.2.1.3. Fluorescence Immunoassays

6.2.2. Radioimmunoassay
6.2.3. Rapid Tests
6.2.4. Western Blotting
6.2.5. Enzyme-Linked Immunospot Assays

6.3. Clinical Chemistry

6.3.1. Metabolic Panel
6.3.2. Electrolyte Panel
6.3.3. Liver Panel
6.3.4. Lipid Profile
6.3.5. Renal Profile
6.3.6. Thyroid Function Panel

6.4. Molecular Diagnostics

6.4.1. Polymerase Chain Reaction
6.4.2. Isothermal Nucleic Acid Amplification Technology
6.4.3. Microarray
6.4.4. Hybridization
6.4.5. DNA Sequencing & Next-Generation Sequencing

6.5. Microbiology
6.6. Hematology
6.7. Coagulation and Hemostasis
6.8. Urinalysis
6.9. Other IVD Technologies

7. In Vitro Diagnostics Market, by Application

7.1. Introduction
7.2. Infectious Diseases
7.3. Oncology
7.4. Endocrinology
7.5. Diabetes
7.6. Cardiology
7.7. Nephrology
7.8. Other Applications

8. Global In Vitro Diagnostics Market, by End Users

8.1. Introduction
8.2. Hospital Laboratories
8.3. Independent Reference Laboratories
8.4. Point-Of-Care Testing
8.5. Patient Self-Testing
8.6. Academic and Research Institutes

9. In Vitro Diagnostics Market, by Geography

9.1. Introduction
9.2. North America

9.2.1. U.S.
9.2.2. Canada

9.3. Europe

9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe

9.4. Asia Pacific

9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia Pacific

9.5. RoW

9.5.1. Latin America
9.5.2. Middle East and Africa

10. Competitive Landscape

10.1. Competitive Benchmarking

11. Company Profiles

11.1. Thermo Fisher Scientific Inc.

11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Recent Developments

11.2. Danaher Corporation

11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Recent Developments

11.3. Abbott Laboratories

11.3.1. Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Recent Developments

11.4. Bio-Rad Laboratories, Inc.

11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Recent Developments

11.5. Ortho Clinical Diagnostics (A Part of Carlyle Group)

11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.5.4. Recent Developments

11.6. Siemens Healthcare GmbH (Subsidiary of Siemens AG)

11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Recent Developments

11.7. Sysmex Corporation

11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Recent Developments

11.8. Becton, Dickinson And Company

11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Recent Developments

11.9. Biomérieux SA

11.9.1. Business Overview
11.9.2. Financial Overview
11.9.3. Product Portfolio
11.9.4. Recent Developments

11.10. Diasorin S.P.A.

11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Recent Development

11.11. Qiagen N.V.

11.11.1. Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Recent Developments

11.12. Agilent Technologies, Inc.

11.12.1. Business Overview
11.12.2. Financial Overview
11.12.3. Product Portfolio
11.12.4. Recent Developments

11.13. F. Hoffmann-La Roche Ltd

11.13.1. Business Overview
11.13.2. Financial Overview
11.13.3. Product Portfolio
11.13.4. Recent Developments

12. Appendix

12.1. Questionnaire
12.2. Available Customization

LIST OF TABLES & FIGURES

List of Tables

Table 1 Global IVD Market Drivers: Impact Analysis (2018–2024)
Table 2 Global IVD Market Restraints: Impact Analysis (2018–2024)
Table 3 Emerging Biomarkers
Table 4 Global IVD Market Size, By Product, 2016-2024 ($ Million)
Table 5 Cost of IVD Reagents and Kits
Table 6 Global IVD Reagents and Kits Market Size, By Country/Region, 2016-2024 ($ Million)
Table 7 Cost of IVD Instruments
Table 8 IVD Instruments Provided by The Leading Players
Table 9 Global IVD Instruments Market Size, By Country/Region, 2016-2024 ($ Million)
Table 10 IVD Software Provided by The Leading Players
Table 11 Global IVD Software and Services Market Size, By Country/Region, 2016-2024 ($ Million)
Table 12 Global IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 13 Global Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 14 Global Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
Table 15 Technologies Used in ELISA
Table 16 Global ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 17 Global ELISA Market Size, By Country/Region, 2016-2024 ($ Million)
Table 18 Global Colorimetric Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
Table 19 Global Chemiluminescence Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
Table 20 Global Fluorescence Immunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
Table 21 Key Rapid Test Analyzers
Table 22 Global Rapid Test Market Size, By Country/Region, 2016-2024 ($ Million)
Table 23 Global Radioimmunoassay Market Size, By Country/Region, 2016-2024 ($ Million)
Table 24 Global Western Blotting Market Size, By Country/Region, 2016-2024 ($ Million)
Table 25 Elispot V.S. Conventional ELISA
Table 26 Global Enzyme Linked Immunospot Assay Market Size, By Country/Region, 2016-2024 ($ Million)
Table 27 Key Clinical Chemistry Panel Tests
Table 28 Global Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 29 Global Clinical Chemistry Market Size, By Country/Region, 2016-2024 ($ Million)
Table 30 Global Metabolic Panel Market Size, By Country/Region, 2016-2024 ($ Million)
Table 31 Electrolyte Panel Analyzers Costs
Table 32 Global Electrolyte Panel Market Size, By Country/Region, 2016-2024 ($ Million)
Table 33 Global Liver Panel Market Size, By Country/Region, 2016-2024 ($ Million)
Table 34 Global Lipid Profile Market Size, By Country/Region, 2016-2024 ($ Million)
Table 35 Global Renal Profile Market Size, By Country/Region, 2016-2024 ($ Million)
Table 36 Global Thyroid Function Panel Market Size, By Technique, 2016-2024 ($ Million)
Table 37 Global Molecular Diagnostics Market Size, By Technique, 2016-2024 ($ Million)
Table 38 Global Molecular Diagnostics Market Size, By Country/Region, 2016-2024 ($ Million)
Table 39 Global Polymerase Chain Reaction Market Size, By Country/Region, 2016-2024 ($ Million)
Table 40 Global Isothermal Nucleic Acid Amplification Technology Market Size, By Country/Region, 2016-2024 ($ Million)
Table 41 Global Hybridization Market Size, By Country/Region, 2016-2024 ($ Million)
Table 42 Global DNA Sequencing & NGS Market Size, By Country/Region, 2016-2024 ($ Million)
Table 43 Global Microarray Market Size, By Country/Region, 2016-2024 ($ Million)
Table 44 Global IVD Market Size for Microbiology, By Country/Region, 2016-2024 ($ Million)
Table 45 Global IVD Market Size for Hematology, By Country/Region, 2016-2024 ($ Million)
Table 46 Global Coagulation and Hemostasis Market Size, By Country/Region, 2016-2024 ($ Million)
Table 47 U.S. Diabetes Indicators, 2016
Table 48 Urinalysis Testing Kits and Reagent Costs
Table 49 Global Urinalysis Market Size, By Country/Region, 2016-2024 ($ Million)
Table 50 Global Other IVD Technologies Market Size, By Country/Region, 2016-2024 ($ Million)
Table 51 IVD Market Size, By Application, 2016-2024 ($ Million)
Table 52 IVD Products for Infectious Diseases
Table 53 IVD Market Size for Infectious Diseases, By Country/Region, 2016-2024 ($ Million)
Table 54 IVD Products for Diabetes
Table 55 IVD Market Size for Diabetes, By Country/Region, 2016-2024 ($ Million)
Table 56 Molecular Diagnostic Products for Oncology
Table 57 IVD Market Size for Oncology, By Country/Region, 2016-2024 ($ Million)
Table 58 IVD Market Size for Endocrinology, By Country/Region, 2016-2024 ($ Million)
Table 59 Key Players Providing IVD Products for Cardiology
Table 60 IVD Market Size for Cardiology, By Country/Region, 2016-2024 ($ Million)
Table 61 IVD Products for Nephrology
Table 62 IVD Market Size for Nephrology, By Country/Region, 2016-2024 ($ Million)
Table 63 IVD Products for Autoimmune and Pulmonary Diseases
Table 64 IVD Market Size for Other Applications, By Country/Region, 2016-2024 ($ Million)
Table 65 Global IVD Market Size, By End Users, 2016-2024 ($ Million)
Table 66 Global IVD Market Size for Hospital Laboratories, By Country/Region, 2016-2024 ($ Million)
Table 67 Global IVD Market Size for Independent Reference Laboratories, By Country/Region, 2016-2024 ($ Million)
Table 68 Global IVD Market Size for PoC Testing, By Country/Region, 2016-2024 ($ Million)
Table 69 Global IVD Market Size for Patient Self-Testing, By Country/Region, 2016-2024 ($ Million)
Table 70 Global IVD Market Size for Academic And Research Institutes, By Country/Region, 2016-2024 ($ Million)
Table 71 Global IVD Market Size, By Country/Region, 2016-2024 ($ Million)
Table 72 North America: IVD Market Size, By Country, 2016-2024 ($ Million)
Table 73 North America: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 74 North America: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 75 North America: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 76 North America: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 77 North America: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 78 North America: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 79 North America: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 80 North America: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 81 U.S.: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 82 U.S.: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 83 U.S.: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 84 U.S.: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 85 U.S.: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 86 U.S.: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 87 U.S.: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 88 U.S.: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 89 Canada: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 90 Canada: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 91 Canada: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 92 Canada: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 93 Canada: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 94 Canada: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 95 Canada: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 96 Canada: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 97 Europe: IVD Market Size, By Country, 2016-2024 ($Million)
Table 98 Europe: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 99 Europe: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 100 Europe: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 101 Europe: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 102 Europe: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 103 Europe: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 104 Europe: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 105 Europe: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 106 Germany: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 107 Germany: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 108 Germany: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 109 Germany: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 110 Germany: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 111 Germany: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 112 Germany: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 113 Germany: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 114 Italy: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 115 Italy: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 116 Italy: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 117 Italy: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 118 Italy: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 119 Italy: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 120 Italy: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 121 Italy: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 122 France: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 123 France: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 124 France: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 125 France: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 126 France: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 127 France: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 128 France: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 129 France: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 130 U.K.: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 131 U.K.: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 132 U.K.: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 133 U.K.: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 134 U.K.: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 135 U.K.: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 136 U.K.: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 137 U.K.: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 138 Spain: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 139 Spain: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 140 Spain: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 141 Spain: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 142 Spain: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 143 Spain: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 144 Spain: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 145 Spain: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 146 Rest of Europe: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 147 Rest of Europe: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 148 Rest of Europe: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 149 Rest of Europe: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 150 Rest of Europe: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 151 Rest of Europe: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 152 Rest of Europe: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 153 Rest of Europe: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 154 Asia Pacific: IVD Market Size, By Country, 2016-2024 ($Million)
Table 155 Asia Pacific: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 156 Asia Pacific: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 157 Asia Pacific: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 158 Asia Pacific: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 159 Asia Pacific: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 160 Asia Pacific: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 161 Asia Pacific: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 162 Asia Pacific: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 163 Japan: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 164 Japan: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 165 Japan: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 166 Japan: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 167 Japan: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 168 Japan: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 169 Japan: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 170 Japan: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 171 China: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 172 China: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 173 China: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 174 China: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 175 China: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 176 China: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 177 China: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 178 China: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 179 India: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 180 India: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 181 India: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 182 India: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 183 India: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 184 India: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 185 India: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 186 India: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 187 Australia: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 188 Australia: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 189 Australia: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 190 Australia: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 191 Australia: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 192 Australia: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 193 Australia: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 194 Australia: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 195 South Korea: Leading Infectious Disease Mortalities, 2015
Table 196 South Korea: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 197 South Korea: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 198 South Korea: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 199 South Korea: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 200 South Korea: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 201 South Korea: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 202 South Korea: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 203 South Korea: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 204 Rest of Asia Pacific: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 205 Rest of Asia Pacific: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 206 Rest of Asia Pacific: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 207 Rest of Asia Pacific: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 208 Rest of Asia Pacific: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 209 Rest of Asia Pacific: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 210 Rest of Asia Pacific: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 211 Rest of Asia Pacific: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 212 Rest of World: IVD Market Size, By Country, 2016-2024 ($ Million)
Table 213 Rest of World: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 214 Rest of World: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 215 Rest of World: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 216 Rest of World: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 217 Rest of World: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 218 Rest of World: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 219 Rest of World: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 220 Rest of World: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 221 Latin America: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 222 Latin America: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 223 Latin America: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 224 Latin America: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 225 Latin America: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 226 Latin America: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 227 Latin America: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 228 Latin America: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 229 Middle East & Africa: IVD Market Size, By Product, 2016-2024 ($ Million)
Table 230 Middle East & Africa: IVD Market Size, By Technique, 2016-2024 ($ Million)
Table 231 Middle East & Africa: Immunoassay Market Size, By Type, 2016-2024 ($ Million)
Table 232 Middle East & Africa: ELISA Market Size, By Type, 2016-2024 ($ Million)
Table 233 Middle East & Africa: Clinical Chemistry Market Size, By Type, 2016-2024 ($ Million)
Table 234 Middle East & Africa: Molecular Diagnostics Market Size, By Type, 2016-2024 ($ Million)
Table 235 Middle East & Africa: IVD Market Size, By Application, 2016-2024 ($ Million)
Table 236 Middle East & Africa: IVD Market Size, By End User, 2016-2024 ($ Million)
Table 237 Number of Developments by the Major Players During 2015-2018
Table 238 Key Products: IVD Reagents & Kits
Table 239 Key Products: IVD Instruments

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Key Opportunities
Figure 6 Key Adopters Of IVD
Figure 7 Immunoassay Technique Dominates the Global IVD Market
Figure 8 Cancer/Oncology Expected to Witness A Fastest Growth in The Global IVD Market During 2018-2024
Figure 9 Patient Self Testing Expected to Witness A Fastest Growth in The Global IVD Market During 2018-2024
Figure 10 Global IVD Market Overview: 2018-2024
Figure 11 Global IVD Market, By Geography, 2017
Figure 12 Market Dynamics
Figure 13 Global Number of Commercially Available Personalized Medicines, 2008-2016
Figure 14 Market Share Analysis: IVD Market, 2017
Figure 15 Global IVD Market Size, By Product, 2018-2024 ($ Million)
Figure 16 Global IVD Market Size, By Technique, 2018-2024 ($ Million)
Figure 17 IVD Market Size, By Application, 2018-2024 ($ Million)
Figure 18 Global HIV And AIDS Data, 2012-2017
Figure 19 Global Number of Cancer Cases, 2018 (In Million)
Figure 20 Global IVD Market Size, By End Users, 2018-2024 ($ Million)
Figure 21 Volume of CLIA Waived PoCT (Units), 2000-2017,
Figure 22 Global Incidence of HIV Infections, 2016 (In Millions)
Figure 23 Global IVD Market Size, By Country/Region, 2018-2024 ($ Million)
Figure 24 North America: IVD Market Size, By Country/Region, 2018-2024 ($ Million)
Figure 25 Europe: IVD Market Size, By Country, 2016-2024 ($ Million
Figure 26 Asia Pacific: IVD Market Size, By Country, 2018-2024 ($ Million)
Figure 27 India: Number of Healthcare Centers, 1981 To March-2015
Figure 28 Rest of World: IVD Market Size, By Country, 2018-2024 ($ Million)
Figure 29 Growth Strategies Adopted by The Key Players Between 2015 And 2018
Figure 30 IVD Market: Competitive Benchmarking
Figure 31 Thermo Fisher Scientific Inc.: Financial Overview (2015-2017)
Figure 32 Danaher Corporation: Financial Overview (2015-2017)
Figure 33 Abbott Laboratories: Financial Overview (2015-2017)
Figure 34 Bio-Rad Laboratories, Inc.:Financial Overview (2015-2017)
Figure 35 Siemens Healthcare GmbH: Financial Overview (2015-2017)
Figure 36 Financial Overview: Sysmex Corporation (2015-2017)
Figure 37 Financial Overview: Becton, Dickinson And Company (2015-2017)
Figure 38 Financial Overview: Biomérieux S.A. (2015-2017)
Figure 39 Financial Overview: Diasorin S.P.A. (2015-2017)
Figure 40 Financial Overview: Qiagen N.V. (2015-2017)
Figure 41 Financial Overview: Agilent Technologies, Inc. (2015-2017)
Figure 42 Financial Overview: F. Hoffmann-La Roche Ltd (2015-2017)

DOWNLOAD SAMPLE

Download Sample

Please fill in the form below to receive the free sample pages of the report.

This website is secure and we do not share your personal information with any third party. Privacy Policy

NEED CUSTOMIZATION?

Need Customization?

Not satisfied with the defined report scope. No worries, we can customize this report for you.
Please fill in the form below and our research analyst will get in touch with you immediately.

This website is secure and we do not share your personal information with any third party. Privacy Policy